• Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (1)
    • Potential targets of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor for multiple sclerosis therapy.
    • See All Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

Potential targets of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor for multiple sclerosis therapy.

Potential targets of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor for multiple sclerosis therapy. J Immunol. 2004 Jan 15; 172(2):1273-86.

View in: PubMed

subject areas
  • Animals
  • Cell Differentiation
  • Cell Line
  • Cell Migration Inhibition
  • Cell Movement
  • DNA-Binding Proteins
  • Encephalomyelitis, Autoimmune, Experimental
  • Epitopes, T-Lymphocyte
  • Female
  • GATA3 Transcription Factor
  • Growth Inhibitors
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Injections, Intraperitoneal
  • Interphase
  • Lovastatin
  • Mice
  • Mice, Inbred Strains
  • Multiple Sclerosis
  • Myelin Proteolipid Protein
  • Neurons
  • Spinal Cord
  • T-Box Domain Proteins
  • Th1 Cells
  • Th2 Cells
  • T-Lymphocyte Subsets
  • Trans-Activators
  • Transcription Factors
  • Up-Regulation

authors with profiles
  • Inderjit Singh
  • Avtar K. Singh